A 64-year-old woman with a past medical history of poorly managed diabetes presents to the emergency department with nausea and vomiting. Her symptoms started yesterday and have been progressively worsening. She is unable to eat given her symptoms. Her temperature is 102°F (38.9°C), blood pressure is 115/68 mmHg, pulse is 120/min, respirations are 17/min, and oxygen saturation is 98% on room air. Physical exam is notable for left-sided costovertebral angle tenderness, and urinalysis demonstrates bacteriuria and pyuria. The patient is admitted to the hospital and started on IV ceftriaxone. On day 3 of her hospital stay she is afebrile, able to eat and drink, and feels better. Which of the following antibiotic regimens should be started or continued as an outpatient upon discharge?
Q2
An 87-year-old male nursing home resident is currently undergoing antibiotic therapy for the treatment of a decubitus ulcer. One week into the treatment course, he experiences several episodes of watery diarrhea. Subsequent sigmoidoscopy demonstrates the presence of diffuse yellow plaques on the mucosa of the sigmoid colon. Which of the following is the best choice of treatment for this patient?
Q3
An 18-year-old female college student is brought to the emergency department by ambulance for a headache and altered mental status. The patient lives with her boyfriend who is with her currently. He states she had not been feeling well for the past day and has vomited several times in the past 12 hours. Lumbar puncture is performed in the emergency room and demonstrates an increased cell count with a neutrophil predominance and gram-negative diplococci on Gram stain. The patient is started on vancomycin and ceftriaxone. Which of the following is the best next step in management?
Q4
A 24-year-old woman presents to the ED with symptoms of pelvic inflammatory disease despite being previously treated with azithromycin for chlamydial infection. Based on your clinical understanding about the epidemiology of PID, you decide to obtain a gram stain which shows a gram-negative diplococci. What is the next step in order to confirm the identity of the organism described?
Q5
A research group wants to assess the safety and toxicity profile of a new drug. A clinical trial is conducted with 20 volunteers to estimate the maximum tolerated dose and monitor the apparent toxicity of the drug. The study design is best described as which of the following phases of a clinical trial?
Q6
A scientist is studying the mechanisms by which bacteria become resistant to antibiotics. She begins by obtaining a culture of vancomycin-resistant Enterococcus faecalis and conducts replicate plating experiments. In these experiments, colonies are inoculated onto a membrane and smeared on 2 separate plates, 1 containing vancomycin and the other with no antibiotics. She finds that all of the bacterial colonies are vancomycin resistant because they grow on both plates. She then maintains the bacteria in liquid culture without vancomycin while she performs her other studies. Fifteen generations of bacteria later, she conducts replicate plating experiments again and finds that 20% of the colonies are now sensitive to vancomycin. Which of the following mechanisms is the most likely explanation for why these colonies have become vancomycin sensitive?
Q7
A student health coordinator plans on leading a campus-wide HIV screening program that will be free for the entire undergraduate student body. The goal is to capture as many correct HIV diagnoses as possible with the fewest false positives. The coordinator consults with the hospital to see which tests are available to use for this program. Test A has a sensitivity of 0.92 and a specificity of 0.99. Test B has a sensitivity of 0.95 and a specificity of 0.96. Test C has a sensitivity of 0.98 and a specificity of 0.93. Which of the following testing schemes should the coordinator pursue?
Q8
You are treating a neonate with meningitis using ampicillin and a second antibiotic, X, that is known to cause ototoxicity. What is the mechanism of antibiotic X?
Q9
A 54-year-old man presents with fever, abdominal pain, nausea, and bloody diarrhea. He says that his symptoms started 36 hours ago and have not improved. Past medical history is significant for a left-leg abscess secondary to an injury he sustained from a fall 4 days ago while walking his dog. He has been taking clindamycin for this infection. In addition, he has long-standing gastroesophageal reflux disease, managed with omeprazole. His vital signs include: temperature 38.5°C (101.3°F), respiratory rate 19/min, heart rate 90/min, and blood pressure 110/70 mm Hg. Which of the following is the best course of treatment for this patient’s most likely diagnosis?
Q10
A 29-year-old pregnant woman with no prior antibiotic exposure presents with gonorrhea. Culture of Neisseria gonorrhoeae shows resistance to penicillin, tetracycline, and fluoroquinolones. Genetic testing reveals she has a strain with chromosomal mutations in penA (mosaic allele), mtrR promoter, and gyrA. She reports her partner recently returned from Southeast Asia. Apply epidemiologic and resistance mechanism knowledge to determine the most appropriate management and public health action.
Antimicrobial stewardship principles US Medical PG Practice Questions and MCQs
Question 1: A 64-year-old woman with a past medical history of poorly managed diabetes presents to the emergency department with nausea and vomiting. Her symptoms started yesterday and have been progressively worsening. She is unable to eat given her symptoms. Her temperature is 102°F (38.9°C), blood pressure is 115/68 mmHg, pulse is 120/min, respirations are 17/min, and oxygen saturation is 98% on room air. Physical exam is notable for left-sided costovertebral angle tenderness, and urinalysis demonstrates bacteriuria and pyuria. The patient is admitted to the hospital and started on IV ceftriaxone. On day 3 of her hospital stay she is afebrile, able to eat and drink, and feels better. Which of the following antibiotic regimens should be started or continued as an outpatient upon discharge?
A. Amoxicillin
B. Nitrofurantoin
C. Ciprofloxacin
D. Ceftriaxone
E. Trimethoprim-sulfamethoxazole (Correct Answer)
Explanation: ***Trimethoprim-sulfamethoxazole***
- This patient presents with **acute pyelonephritis**, indicated by fever, CVA tenderness, bacteriuria, and pyuria, requiring a 7-14 day course of treatment.
- After 3 days of IV ceftriaxone with clinical improvement, **step-down to oral therapy** is appropriate.
- **Trimethoprim-sulfamethoxazole** is a first-line oral agent for completing treatment of uncomplicated pyelonephritis and is preferred when **local resistance rates are <20%** and no specific resistance data is available.
- It achieves adequate concentrations in renal tissue and is cost-effective for outpatient therapy.
*Amoxicillin*
- **Amoxicillin** is not recommended for pyelonephritis due to **high resistance rates** among common uropathogens like *E. coli* (often >30%).
- It does not achieve adequate concentrations in the renal parenchyma to effectively treat **upper urinary tract infections**.
*Nitrofurantoin*
- **Nitrofurantoin** is concentrated in the bladder and is highly effective for **lower urinary tract infections (cystitis)**.
- It is **contraindicated for pyelonephritis** because it does not reach therapeutic levels in the renal parenchyma or bloodstream.
- Additionally, it should be avoided in patients with impaired renal function.
*Ciprofloxacin*
- **Ciprofloxacin** is also a first-line oral agent for pyelonephritis and would be an appropriate choice for step-down therapy.
- However, when no culture or susceptibility data is available, **TMP-SMX is generally preferred** as an initial oral choice due to concerns about promoting fluoroquinolone resistance and potential adverse effects (tendonitis, QT prolongation, C. difficile).
- Fluoroquinolones are particularly valuable when reserved for cases with known resistance to other agents or specific patient contraindications.
*Ceftriaxone*
- **Ceftriaxone** is an IV third-generation cephalosporin used for initial empiric treatment of acute pyelonephritis in hospitalized patients.
- Once the patient is **clinically stable, afebrile, and tolerating oral intake**, transitioning to oral therapy is standard practice.
- Continued IV therapy as an outpatient is unnecessarily invasive and costly when oral options are effective.
Question 2: An 87-year-old male nursing home resident is currently undergoing antibiotic therapy for the treatment of a decubitus ulcer. One week into the treatment course, he experiences several episodes of watery diarrhea. Subsequent sigmoidoscopy demonstrates the presence of diffuse yellow plaques on the mucosa of the sigmoid colon. Which of the following is the best choice of treatment for this patient?
A. Intravenous vancomycin
B. Intravenous gentamicin
C. Oral metronidazole (Correct Answer)
D. Oral trimethoprim/sulfamethoxazole
E. Oral morphine
Explanation: ***Oral metronidazole***
- The patient's presentation with **watery diarrhea** and **yellow plaques (pseudomembranes) on sigmoidoscopy** after antibiotic therapy is classic for **Clostridioides difficile infection (CDI)**.
- Among the options provided, **oral metronidazole** is the best choice as it achieves therapeutic concentrations in the colonic lumen and has activity against C. difficile.
- Current **IDSA guidelines** recommend oral **vancomycin or fidaxomicin** as first-line therapy for CDI; however, metronidazole remains an acceptable alternative, particularly in resource-limited settings or when first-line agents are unavailable.
- Metronidazole has good **colonic penetration** when administered orally and is effective against anaerobic bacteria including C. difficile.
*Intravenous vancomycin*
- While **vancomycin** is highly effective against C. difficile, it **must be administered orally** to treat CDI because IV vancomycin does not achieve adequate concentrations in the gut lumen.
- Intravenous vancomycin is excreted primarily by the kidneys and does not reach the colonic mucosa in therapeutic amounts.
- IV vancomycin is appropriate for systemic infections like **MRSA bacteremia or endocarditis**, but not for intestinal infections like CDI.
*Intravenous gentamicin*
- **Gentamicin** is an aminoglycoside antibiotic effective against **gram-negative bacteria** but has **no activity against C. difficile**, which is a gram-positive anaerobic bacillus.
- Aminoglycosides carry significant risks of **nephrotoxicity and ototoxicity**, making them inappropriate for this clinical scenario.
- Use of gentamicin would not address the underlying CDI and could worsen outcomes.
*Oral trimethoprim/sulfamethoxazole*
- **Trimethoprim/sulfamethoxazole** is a broad-spectrum antibiotic effective for various infections (UTIs, Pneumocystis, etc.) but has **no significant activity against C. difficile**.
- Continued antibiotic use with agents ineffective against C. difficile could further disrupt normal gut flora and potentially **worsen the CDI**.
*Oral morphine*
- **Morphine** is an opioid analgesic with **no antibacterial properties** and therefore cannot treat bacterial infections like CDI.
- Opioids can actually **slow gastrointestinal motility**, which may worsen outcomes in CDI by prolonging exposure to toxins.
- While it might provide symptomatic relief of abdominal discomfort, it does not address the underlying infection and is contraindicated in infectious diarrhea.
Question 3: An 18-year-old female college student is brought to the emergency department by ambulance for a headache and altered mental status. The patient lives with her boyfriend who is with her currently. He states she had not been feeling well for the past day and has vomited several times in the past 12 hours. Lumbar puncture is performed in the emergency room and demonstrates an increased cell count with a neutrophil predominance and gram-negative diplococci on Gram stain. The patient is started on vancomycin and ceftriaxone. Which of the following is the best next step in management?
A. Treat boyfriend with rifampin (Correct Answer)
B. Add ampicillin to treatment regimen
C. Add ampicillin, dexamethasone, and rifampin to treatment regimen
D. Add dexamethasone to treatment regimen
E. Treat boyfriend with ceftriaxone and vancomycin
Explanation: ***Treat boyfriend with rifampin***
- The patient's presentation with headache, altered mental status, neutrophilic pleocytosis, and **Gram-negative diplococci** on CSF Gram stain is highly suggestive of **Neisseria meningitidis** meningitis.
- The patient is already on appropriate empiric antibiotic therapy (vancomycin and ceftriaxone), so the **immediate priority** is to prevent secondary cases through **post-exposure prophylaxis** for close contacts.
- Close contacts, including household members like the boyfriend, are at high risk of contracting the infection and should receive prophylaxis within **24 hours** of case identification, with **rifampin**, **ciprofloxacin**, or **IM ceftriaxone** being standard options.
*Add ampicillin to treatment regimen*
- Ampicillin provides coverage for **Listeria monocytogenes**, but the Gram stain demonstrating **Gram-negative diplococci** makes Listeria (Gram-positive rod) unlikely in this otherwise healthy young adult without specific risk factors for Listeria.
- The current regimen of vancomycin and ceftriaxone provides adequate empiric coverage for acute bacterial meningitis, targeting common pathogens like **S. pneumoniae** and **N. meningitidis**.
*Add ampicillin, dexamethasone, and rifampin to treatment regimen*
- While providing rifampin prophylaxis to the boyfriend is appropriate, adding it to the **patient's** treatment regimen is not indicated for her active infection.
- **Dexamethasone** is often added to reduce inflammation and neurological sequelae but should be given **prior to or concurrently** with the first dose of antibiotics; adding it later in the course may not be as beneficial.
- This option conflates treatment of the patient with prophylaxis of contacts.
*Add dexamethasone to treatment regimen*
- Dexamethasone is recommended in adults with suspected pneumococcal meningitis to reduce mortality and neurological sequelae, but ideal administration is **prior to or with the first dose of antibiotics**.
- While it might still be considered, the priority given the **Gram-negative diplococci** (suggesting N. meningitidis rather than S. pneumoniae) is **contact prophylaxis** to prevent further spread, and the timing for optimal dexamethasone benefit has likely passed.
*Treat boyfriend with ceftriaxone and vancomycin*
- Ceftriaxone and vancomycin are appropriate for treating the patient's active meningitis, but they are not the standard or preferred agents for **post-exposure prophylaxis** in contacts.
- Post-exposure prophylaxis typically involves a short course of agents like **rifampin**, **ciprofloxacin**, or a single dose of **intramuscular ceftriaxone**, primarily to eradicate nasopharyngeal carriage and prevent transmission.
Question 4: A 24-year-old woman presents to the ED with symptoms of pelvic inflammatory disease despite being previously treated with azithromycin for chlamydial infection. Based on your clinical understanding about the epidemiology of PID, you decide to obtain a gram stain which shows a gram-negative diplococci. What is the next step in order to confirm the identity of the organism described?
A. Perform an RT-PCR
B. Culture in TCBS agar
C. Culture in Thayer-Martin media (Correct Answer)
D. Obtain an acid fast stain
E. Culture in Bordet-Gengou agar
Explanation: ***Culture in Thayer-Martin media***
- The presence of **gram-negative diplococci** in a patient with PID symptoms strongly suggests *Neisseria gonorrhoeae*.
- **Thayer-Martin media** is a selective **agar** specifically designed for the isolation and identification of *Neisseria* species, including *N. gonorrhoeae*, by inhibiting the growth of most commensal bacteria and fungi.
*Perform an RT-PCR*
- While **RT-PCR** can detect *Neisseria gonorrhoeae* nucleic acids, it is primarily used for **molecular diagnosis** and not directly for confirming the identity of a cultured organism visualized on gram stain.
- **RT-PCR** is generally used for direct detection from clinical samples and is particularly useful in situations where culture is difficult or unavailable.
*Culture in TCBS agar*
- **TCBS (Thiosulfate Citrate Bile Salts Sucrose) agar** is a selective medium primarily used for the isolation of *Vibrio* species, which are not typically associated with pelvic inflammatory disease or characterized as gram-negative diplococci.
- This medium is designed to differentiate between different *Vibrio* species based on sucrose fermentation.
*Obtain an acid fast stain*
- An **acid-fast stain** (e.g., Ziehl-Neelsen stain) is used to identify bacteria with a **waxy cell wall**, such as *Mycobacterium* species (e.g., *Mycobacterium tuberculosis*).
- *Neisseria gonorrhoeae* is not acid-fast, and this stain would not be appropriate for its identification.
*Culture in Bordet-Gengou agar*
- **Bordet-Gengou agar** is a specialized culture medium used for the isolation of *Bordetella pertussis*, the causative agent of whooping cough.
- This medium is not suitable for the isolation of *Neisseria gonorrhoeae*.
Question 5: A research group wants to assess the safety and toxicity profile of a new drug. A clinical trial is conducted with 20 volunteers to estimate the maximum tolerated dose and monitor the apparent toxicity of the drug. The study design is best described as which of the following phases of a clinical trial?
A. Phase 0
B. Phase III
C. Phase V
D. Phase II
E. Phase I (Correct Answer)
Explanation: ***Phase I***
- **Phase I clinical trials** involve a small group of healthy volunteers (typically 20-100) to primarily assess **drug safety**, determine a safe dosage range, and identify side effects.
- The main goal is to establish the **maximum tolerated dose (MTD)** and evaluate the drug's pharmacokinetic and pharmacodynamic profiles.
*Phase 0*
- **Phase 0 trials** are exploratory studies conducted in a very small number of subjects (10-15) to gather preliminary data on a drug's **pharmacodynamics and pharmacokinetics** in humans.
- They involve microdoses, not intended to have therapeutic effects, and thus cannot determine toxicity or MTD.
*Phase III*
- **Phase III trials** are large-scale studies involving hundreds to thousands of patients to confirm the drug's **efficacy**, monitor side effects, compare it to standard treatments, and collect information that will allow the drug to be used safely.
- These trials are conducted after safety and initial efficacy have been established in earlier phases.
*Phase V*
- "Phase V" is not a standard, recognized phase in the traditional clinical trial classification (Phase 0, I, II, III, IV).
- This term might be used in some non-standard research contexts or for post-marketing studies that go beyond Phase IV surveillance, but it is not a formal phase for initial drug development.
*Phase II*
- **Phase II trials** involve several hundred patients with the condition the drug is intended to treat, focusing on **drug efficacy** and further evaluating safety.
- While safety is still monitored, the primary objective shifts to determining if the drug works for its intended purpose and at what dose.
Question 6: A scientist is studying the mechanisms by which bacteria become resistant to antibiotics. She begins by obtaining a culture of vancomycin-resistant Enterococcus faecalis and conducts replicate plating experiments. In these experiments, colonies are inoculated onto a membrane and smeared on 2 separate plates, 1 containing vancomycin and the other with no antibiotics. She finds that all of the bacterial colonies are vancomycin resistant because they grow on both plates. She then maintains the bacteria in liquid culture without vancomycin while she performs her other studies. Fifteen generations of bacteria later, she conducts replicate plating experiments again and finds that 20% of the colonies are now sensitive to vancomycin. Which of the following mechanisms is the most likely explanation for why these colonies have become vancomycin sensitive?
A. Point mutation
B. Gain of function mutation
C. Viral infection
D. Plasmid loss (Correct Answer)
E. Loss of function mutation
Explanation: ***Plasmid loss***
- The initial **vancomycin resistance** in *Enterococcus faecalis* is often mediated by genes located on **plasmids**, which are extrachromosomal DNA.
- In the absence of selective pressure (vancomycin), bacteria that lose the plasmid (and thus the resistance genes) have a **growth advantage** over those that retain the energetically costly plasmid, leading to an increase in sensitive colonies over generations.
*Point mutation*
- A **point mutation** typically involves a change in a single nucleotide and could lead to loss of resistance if it occurred in a gene conferring resistance.
- However, since there was no selective pressure for loss of resistance, it is less likely that 20% of the population would acquire such a specific point mutation to revert resistance.
*Gain of function mutation*
- A **gain of function mutation** would imply that the bacteria acquired a *new* advantageous trait, not the *loss* of resistance.
- This type of mutation would not explain why some colonies became sensitive to vancomycin after the drug was removed.
*Viral infection*
- **Viral infection** (bacteriophages) can transfer genes through transduction or cause bacterial lysis, but it's not the primary mechanism for a widespread reversion of resistance in the absence of antibiotic pressure.
- It would not explain the observed increase in vancomycin-sensitive colonies due to evolutionary pressure.
*Loss of function mutation*
- While a **loss of function mutation** in a gene conferring resistance could lead to sensitivity, it's generally less likely to explain a 20% shift without selective pressure than **plasmid loss**.
- Plasmids are often unstable and are easily lost in the absence of selection, whereas a specific gene mutation causing loss of function would need to arise and become prevalent in the population.
Question 7: A student health coordinator plans on leading a campus-wide HIV screening program that will be free for the entire undergraduate student body. The goal is to capture as many correct HIV diagnoses as possible with the fewest false positives. The coordinator consults with the hospital to see which tests are available to use for this program. Test A has a sensitivity of 0.92 and a specificity of 0.99. Test B has a sensitivity of 0.95 and a specificity of 0.96. Test C has a sensitivity of 0.98 and a specificity of 0.93. Which of the following testing schemes should the coordinator pursue?
A. Test A on the entire student body followed by Test B on those who are positive
B. Test A on the entire student body followed by Test C on those who are positive
C. Test C on the entire student body followed by Test B on those who are positive
D. Test C on the entire student body followed by Test A on those who are positive (Correct Answer)
E. Test B on the entire student body followed by Test A on those who are positive
Explanation: ***Test C on the entire student body followed by Test A on those who are positive***
- To "capture as many correct HIV diagnoses as possible" (maximize true positives), the initial screening test should have the **highest sensitivity**. Test C has the highest sensitivity (0.98).
- To "capture as few false positives as possible" (maximize true negatives and confirm diagnoses), the confirmatory test should have the **highest specificity**. Test A has the highest specificity (0.99).
*Test A on the entire student body followed by Test B on those who are positive*
- Starting with Test A (sensitivity 0.92) would miss more true positive cases than starting with Test C (sensitivity 0.98), failing the goal of **capturing as many cases as possible**.
- Following with Test B (specificity 0.96) would result in more false positives than following with Test A (specificity 0.99).
*Test A on the entire student body followed by Test C on those who are positive*
- This scheme would miss many true positive cases initially due to Test A's lower sensitivity compared to Test C.
- Following with Test C would introduce more false positives than necessary, as it has a lower specificity (0.93) than Test A (0.99).
*Test C on the entire student body followed by Test B on those who are positive*
- While Test C is a good initial screen for its high sensitivity, following it with Test B (specificity 0.96) is less optimal than Test A (specificity 0.99) for minimizing false positives in the confirmation step.
- This combination would therefore yield more false positives in the confirmatory stage than using Test A.
*Test B on the entire student body followed by Test A on those who are positive*
- Test B has a sensitivity of 0.95, which is lower than Test C's sensitivity of 0.98, meaning it would miss more true positive cases at the initial screening stage.
- While Test A provides excellent specificity for confirmation, the initial screening step is suboptimal for the goal of capturing as many diagnoses as possible.
Question 8: You are treating a neonate with meningitis using ampicillin and a second antibiotic, X, that is known to cause ototoxicity. What is the mechanism of antibiotic X?
A. It binds the 50S ribosomal subunit and inhibits formation of the initiation complex
B. It binds the 30S ribosomal subunit and inhibits formation of the initiation complex (Correct Answer)
C. It binds the 30S ribosomal subunit and reversibly inhibits translocation
D. It binds the 50S ribosomal subunit and inhibits peptidyltransferase
E. It binds the 50S ribosomal subunit and reversibly inhibits translocation
Explanation: ***It binds the 30s ribosomal subunit and inhibits formation of the initiation complex***
- The second antibiotic, X, is likely an **aminoglycoside**, such as **gentamicin** or **amikacin**, which are commonly used in combination with ampicillin for neonatal meningitis and are known to cause ototoxicity.
- Aminoglycosides exert their bactericidal effect by **irreversibly binding to the 30S ribosomal subunit**, thereby **inhibiting the formation of the initiation complex** and leading to misreading of mRNA.
*It binds the 50S ribosomal subunit and inhibits formation of the initiation complex*
- This mechanism is characteristic of **linezolid**, which targets the 50S ribosomal subunit to prevent the formation of the initiation complex.
- While linezolid can cause side effects, **ototoxicity** is less commonly associated with it compared to aminoglycosides, and it is not a primary drug for neonatal meningitis alongside ampicillin.
*It binds the 50S ribosomal subunit and inhibits peptidyltransferase*
- This is the mechanism of action for **chloramphenicol**, which inhibits **peptidyltransferase** activity on the 50S ribosomal subunit, preventing peptide bond formation.
- Although chloramphenicol can cause **ototoxicity** and **aplastic anemia**, its use in neonates is limited due to the risk of **Gray Baby Syndrome**.
*It binds the 30s ribosomal subunit and reversibly inhibits translocation*
- This describes the mechanism of action of **tetracyclines**, which reversibly bind to the 30S ribosomal subunit and prevent the attachment of aminoacyl-tRNA, thereby inhibiting protein synthesis.
- Tetracyclines are **contraindicated in neonates** due to their potential to cause **tooth discoloration** and **bone growth inhibition**, and ototoxicity is not their primary adverse effect.
*It binds the 50s ribosomal subunit and reversibly inhibits translocation*
- This mechanism of reversibly inhibiting translocation by binding to the 50S ribosomal subunit is characteristic of **macrolides** (e.g., erythromycin, azithromycin) and **clindamycin**.
- While some macrolides can cause **transient ototoxicity**, they are not typically the second antibiotic of choice for neonatal meningitis in combination with ampicillin, and clindamycin's side effect profile is different.
Question 9: A 54-year-old man presents with fever, abdominal pain, nausea, and bloody diarrhea. He says that his symptoms started 36 hours ago and have not improved. Past medical history is significant for a left-leg abscess secondary to an injury he sustained from a fall 4 days ago while walking his dog. He has been taking clindamycin for this infection. In addition, he has long-standing gastroesophageal reflux disease, managed with omeprazole. His vital signs include: temperature 38.5°C (101.3°F), respiratory rate 19/min, heart rate 90/min, and blood pressure 110/70 mm Hg. Which of the following is the best course of treatment for this patient’s most likely diagnosis?
A. Tetracycline
B. Ciprofloxacin
C. Trimethoprim-sulfamethoxazole
D. Erythromycin
E. Vancomycin (Correct Answer)
Explanation: ***Vancomycin***
- The patient's history of recent **clindamycin** use for an abscess, development of **fever, abdominal pain, nausea, and bloody diarrhea**, and use of **omeprazole** (a risk factor), strongly suggests **_Clostridioides difficile_ infection (CDI)**.
- **Oral vancomycin** is a first-line treatment for **severe non-fulminant CDI**, which this patient's symptoms (fever, bloody diarrhea) are consistent with.
*Tetracycline*
- **Tetracycline** is typically used for bacterial infections like **chlamydia, Lyme disease, and rickettsial infections**; it is not effective against _C. difficile_.
- It works by **inhibiting bacterial protein synthesis** but does not target the cell wall of _C. difficile_.
*Ciprofloxacin*
- **Ciprofloxacin**, a fluoroquinolone, is generally **contraindicated in CDI** as it can be a risk factor for developing the infection or exacerbate it due to disruption of gut flora.
- While effective against many gram-negative bacteria, it has **no significant activity against _C. difficile_**.
*Trimethoprim-sulfamethoxazole*
- **Trimethoprim-sulfamethoxazole** is a combination antibiotic used for various bacterial infections, including **UTIs and some respiratory infections**.
- It is **not effective against _C. difficile_** and is not recommended for its treatment.
*Erythromycin*
- **Erythromycin**, a macrolide, is effective against a range of bacterial infections including **atypical pneumonia and skin infections**.
- It has **no role in the treatment of _C. difficile_ infection** and its use could potentially further disrupt the gut microbiome.
Question 10: A 29-year-old pregnant woman with no prior antibiotic exposure presents with gonorrhea. Culture of Neisseria gonorrhoeae shows resistance to penicillin, tetracycline, and fluoroquinolones. Genetic testing reveals she has a strain with chromosomal mutations in penA (mosaic allele), mtrR promoter, and gyrA. She reports her partner recently returned from Southeast Asia. Apply epidemiologic and resistance mechanism knowledge to determine the most appropriate management and public health action.
A. Treat with ceftriaxone alone and report to local health department
B. Treat with dual therapy (ceftriaxone plus azithromycin) and initiate partner notification with travel history documentation (Correct Answer)
C. Perform cephalosporin susceptibility testing before treatment initiation
D. Treat with azithromycin monotherapy due to pregnancy
E. Initiate spectinomycin therapy and routine partner notification only
Explanation: ***Treat with dual therapy (ceftriaxone plus azithromycin) and initiate partner notification with travel history documentation***
- The presence of the **mosaic penA allele** and **mtrR promoter mutations** signifies significant resistance potential; **dual therapy** with ceftriaxone and azithromycin remains critical for ensuring cure and slowing further resistance in highly resistant strains.
- Given the partner's travel to **Southeast Asia**, a region known for emerging **extensively drug-resistant (XDR)** gonorrhea, documenting travel and notification is vital for public health **surveillance**.
*Treat with ceftriaxone alone and report to local health department*
- While ceftriaxone is the backbone of treatment, using **monotherapy** for a strain already exhibiting multiple chromosomal resistance mutations (mosaic penA) increases the risk of selecting for **cephalosporin resistance**.
- This approach is less robust than dual therapy in the context of suspected **imported resistant strains** from high-risk geographic regions.
*Perform cephalosporin susceptibility testing before treatment initiation*
- Delaying treatment for **Neisseria gonorrhoeae** waiting for susceptibility results is inappropriate as it allows for ongoing **transmission** and potential progression to **pelvic inflammatory disease**.
- Clinical guidelines recommend **empiric treatment** based on local prevalence and travel history while simultaneously performing surveillance cultures.
*Treat with azithromycin monotherapy due to pregnancy*
- **Azithromycin monotherapy** is contraindicated for gonorrhea treatment because it has a low barrier to resistance and would fail to cover chromosomal mutations affecting **efflux pumps (mtrR)**.
- While both drugs are safe in **pregnancy**, azithromycin must be used in **combination** with ceftriaxone to prevent treatment failure.
*Initiate spectinomycin therapy and routine partner notification only*
- **Spectinomycin** is a second-line agent that is currently not readily available in the United States and has poor efficacy for **pharyngeal infections**.
- Focusing only on routine notification ignores the critical **epidemiologic significance** of the Southeast Asian travel history associated with highly resistant strains.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
